dependent; RBCs from humans, rabbits, rats, and sheep were lysed with both autologous and all heterologous sera. Both biotinylated and native cells were not lysed. Lysis was observed at an avidin surface density of about 10' molecules per cell. Acylation of avidin prevents lysis and decreases the positive charge of the avidin. Lysis depends on the length of the cross-linking agent used for the biotin attachment to the membrane. An increase in the length of the cross-linking agent was accompanied by an enhancement of the lysis and the agglutination titer of biotinylated RBCs in a solution of HE ALTERNATIVE pathway of complement (APC)
T is triggered by the absence of immune complexes, without binding and activation of C1. Spontaneous autoactivation of C3 due to hydrolysis of the inner thioester bond permanently occurs in the liquid phase, and direct binding of the formed C3b to the membrane of cell activator generates an active APC convertase.' Hence, normal cells must possess an effective mechanism of APC restriction. Generally, sialic acids,' decay accelerating factor (DAF),3 type 1 receptor for complement (CR1); and some other components of the cell membrane' serve as endogenous regulators of APC convertase or as cofactors of serum APC regulators. Additionally, lysis by homologous complement in mammals is strongly restricted by specific membrane proteins: homologous restriction factor (HRF),6 CS-binding protein (CSbp),' and membrane inhibitor of reactive lysis (MIRL).' The elimination of the APC restriction may lead to hemolysis, which is observed in certain forms of paroxysmal nocturnal hemoglobin~ria~~'~ and some other diseases.'' On the other hand, some and ba~terial'~.'~ cells exhibit a high resistance to complement (in certain cases as a result of effective APC restriction). Thus, APC restriction is involved both in blood pathology and in the competency of antitumor and antibacterial resistence. This finding generated a great interest in the mechanisms of endogenous APC restriction and cell conversion to APC activators.
Certain alterations in the membrane of the cells that normally are not activators of the alternative pathway convert them to APC activators. It has been reported that de~ialization,'~-'~ influenzam or Epstein-Bar?' virus (EBV) infection, steric masking or blockade of endogenous APC inhibitors by antibodies,= and treatment with phospholipase CZ result in APC activation. All these interventions lead to the formation of noninhibiting sites for APC convertase binding and altered interactions between membrane-bound C3b and inhibitors or cofactors of APC convertase.
We report a new means for elimination of APC restriction in mammalian red blood cells (RBCs), a noncovalent attachment of avidin to the membrane of prebiotinylated cells. Avidin-carrying erythrocytes from humans, rabbits, sheep, and rats were lysed with both heterologous and homologous sera via the APC. Acylation of avidin prevents avidin. It is suggested that avidin attachment induces some transformations of the cell membrane that lead to the conversion from "APC nonactivator" cells to "APC activator" cells. The interaction of avidin with membrane APC-restrictors (decay-accelerating factors, type 1 receptor for complement, homologous restriction factor, and others), the charge of avidin, and its cross-linking ability in lysis are discussed. It is proposed that membrane rearrangement induced by multipoint avidin attachment to biotinylated membrane is the main reason for avidin-induced elimination of APC restriction. 0 1991 by The American Society of Hematology.
APC activation. It is noteworthy that the avidin-induced conversion of the biotinylated cell to APC activator depends on the choice of the cross-linking agent. An increase in the length of the cross-linking agent leads to a considerable increase in lysis.
MATERIALS AND METHODS
Avidin was purified from hen egg whitez4 and its activity was determined by spectrophotometric titration with biotiaZ5 Bovine serum albumin (BSA), biotin N-hydroxysuccinimide ester (BoSu), trinitrobenzolsulfonic acid (TNBS), and buffer components were from Sigma (St Louis, MO). Blood from healthy volunteers and from animals was collected in acid-citrate-dextrose anticoagulant.
Fifty microliters of 0 to 80 mmol/L succinic anhydride in dimethylformamide was added to 1 mL avidin (1 mg/mL in 0.1 mol/L sodium tetraborate, pH 9.2) and incubated at 0°C for 1 hour. The number of substituted amino groups was determined by titration with TNBS.z6 The reaction mixture was excessively dialyzed against phosphate-buffered saline (PBS) (138 mmol/L NaCI, 2.7 mmol/L KCI, 8.1 mmol/L Na'HPO,, and 1.5 mmol/L KHzP04, pH 7.4).
Procedures were performed as previously de~cribed.'~ Briefly, sodium tetraborate (0.1 mL of 0.1 mol/L) and 3 p, L of 0.1 mol/L BoSu in dimethylformamide were sequentially added to 1 mL of 10% PBS-washed erythrocyte suspension. The reaction mixture was incubated at 20°C for 20 minutes and cells were then washed with PBS (five times in 15 mL). Then 0.01 to 1 mg of avidin in 1 mL PBS was added to 1 mL of a 10% suspension of biotin-carrying erythrocytes at constant stirring. After 20 to 60 minutes of incubation at 4°C with periodical shaking, erythrocytes were washed three times with 15 mL of PBS. To quantitate protein binding to erythrocyte surface, the avidin were labeled with 'ZSI-Bolton-Hunter reagent Avidin acylation.
Avidin immobilization on elythrocyte surface.
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(Amersham, Aylesbury, UK) according to the manufacturer's procedures.
The hemolytic assay was performed in microtitration plates as described previously.z Veronal-buffered saline (VBS) was used (4 mmol/L veronal buffer containing 3 mmol/L diethylbarbituric acid, 1 mmol/L sodium salt of diethylbarbituric acid, 145 mmol/L NaC1, 0.25 mmol/L CaCl,, 1.5 mmol/L MgCl,, pH 7.2). Complement was twofold serially diluted in 50 p L of VBS and then 50 )LL of 2% suspension of the erythrocytes being tested was added. Wells with complement-free VBS and erythrocytes were used as a zero standard. One hundred percent hemolysis was attained by the addition of distilled water instead of VBS. The plates were incubated at 37°C for 60 minutes and the degree of hemolysis was determined as absorbance at 630 nm using an MR-580 Micro Elisa Auto Reader (Dinatech, Alexandria, VA).
Testingof the avidin-induced hemolysis.
The percentage of lysis was calculated as:
where A100% is the absorbance corresponding to 100% hemolysis. AO% is the absorbance corresponding to 0% hemolysis, and A is the absorbance at an intermediate experimental point. CH50% was calculated as serum dilution providing 50% lysis.
The synthesis of 6-biotinylamidocaproic acid N-hydroxysuccinimide ester was performed as de~cribed.'~ Testing of the agglutination activity of native and acyfated avidin. PBS-BSA (50 pL) was added to each well of a V-bottomed microtitration plate. Avidin was 2-fold serially diluted in PBS-BSA, then 50 pL of 1% suspension of biotin-carrying erythrocytes was added to each well, carefully mixed, and left for 40 to 60 minutes at 20°C. The agglutination titer was defined as the minimal avidin concentration in the well at which erythrocytes still did not sediment to the center of the bottom. The agglutination titer for native avidin was about 1 pg/mL.
RESULTS
After avidin attachment, biotinylated human erythrocytes were lysed by autologous serum (Fig l) , while native and biotinylated erythrocytes were not. Both lysis and efficiency of avidin attachment were independent of AB0 and Rh blood groups, the binding being about 5 X lo5 avidin molecules per cell (unless particularly specified). Generally, CH50% of lysis was '/s to %6; occasionally (in 1 of 15 to 20 donors), autologous hemolysis was not observed. The hemolytic activity of these "avidin-nonlysing" sera was similar to that of usual "avidin-lysing" sera in tests of sensitized sheep RBCs (EA) lysis via the classical or rabbit RBC lysis via the alternative pathways (not shown). Pooled sera from several donors with the same blood group lysed avidin-carrying biotinylated erythrocytes more efficiently than autologous serum (generally, CH 50% of lysis was 1/20 to 1/40). All experiments described below (unless specified) were performed with freshly prepared pooled homologous sera inducing no detectable hemolysis of avidin-free biotinylated erythrocytes.
Avidin-induced hemolysis was completely eliminated by a 30-minute serum incubation at 56°C or by EDTA (10 mmol/L) treatment (Fig 2) . These data indicate participation of complement in lysis. To find out whether naturally occurring antiavidin antibodies are involved in hemolysis, we used peroxidase-labeled goat antibody against human SERUM DILUTION Igs to show their binding to avidin-coated plastic; however, the binding level was essentially the same as with BSA or ovalbumin coating (data not shown). On the other hand, hemolysis proceeded well in Mg-EGTA ( Fig 2) . This result suggests APC activation without participation of antigen- For personal use only. on October 3, 2017. by guest www.bloodjournal.org From antibody interaction. The relationship between hemolysis and M$' concentration was similar for both avidin-carrying human erythrocytes and native rabbit erythrocyte lysis by human serum and exhibited a bell-like curve of behavior (Fig 3) . It can be seen that the hemolysis increases with the increase in MgZ' concentration up to 1 mmol/L and decreases at concentrations higher than 5 mmol/L. This dependence is characteristic of the alternative pathway.30
RBCs from all of the studied mammalian species were sensitive to avidin-induced lysis. Attachment of avidin resulted in lysis of biotinylated human, rat, rabbit, and sheep erythrocytes (Fig 4) . Avidin-carrying erythrocytes from these species were lysed by both autologous and heterologous sera. Figure 5 shows heterologous hemolysis of avidin-carrying biotinylated rat erythrocytes without hemolysis of avidin-free biotinylated rat cells by human, sheep, rabbit, and autologous sera. In some cases, biotinylated erythrocytes as well as native cells were lysed by heterologous sera (eg, rabbit erythrocytes were lysed by human serum and human cells were lysed by rat serum).
Lysis of avidin-carrying biotinylated erythrocytes depends on the surface density of avidin. Erythrocytes treated with BoSu were lysed after attachment of about lo5 avidin molecules per cell ( Fig 6) . Further increases in avidin density produce gradual augmentation of hemolysis up to plateau at 5 x le molecules per cell; the attachment of up to 5 x lo4 avidin molecules to the erythrocyte membrane did not result in appreciable lysis.
Avidin has a high positive charge (PI about ll)." Acylation of avidin amino groups with succinic anhydride enabled us to obtain avidin fractions with PIS of about 8.5,7.0, and 5.0 (25%, 50%, and 75% of amino groups modification, respectively)?' The ability of avidin to induce hemolysis dramatically decreases with the charge decrease (Fig 7) . We have also examined how hemolysis is influenced by the mode of avidin attachment to the erythrocyte membrane. For this purpose we have compared the lysis of avidin-carrying erythrocytes pretreated with BoSu and 
6-biotinyl amidocaproic acid N-hydroxysuccinimide ester.
In principle, the 6-aminocaproic group may be regarded as an additional spacer with a length of about 7 A.
The efficiency of avidin attachment was similar for both agents ( Table 1 ). Both types of biotinylated erythrocytes were not lysed by complement in absence of avidin and showed similar high stability on storage. However, after avidin attachment, the lysis differed considerably (Fig 8) . lysis was 1/83 versus '/zs for biotinylated erythrocytes. Biotinylamidocaproylated erythrocytes were lysed at a greater rate. The lysis developed during 5 minutes and reached a maximum after 15 minutes. This rate is fourfold higher as compared with the lysis rate for biotinylated avidin-carrying erythrocytes (Fig 9) . The data shown in Fig 10 allow the comparison of the avidin surface densities critical for the lysis of biotinylated and biotinylamidocaproylated erythrocytes. These densities are 2 x lo5 and 8 x lo4 molecules per erythrocyte (at minimal serum dilution used, %). Assuming a random distribution of avidin on the erythrocyte surface, the above values are consistent with the minimal distance between avidin molecules on the membrane of biotinylated and biotinylamidocaproylated erythrocytes, 236 and 444 A (see Table 1 ). Finally, the agglutination titer of biotinylamidocaproylated erythrocytes in avidin solution is higher (0.3 pg of avidin/mL v 1.0 pg/mL for biotinylated cells), although the number of attached avidin molecules is similar with both agents.
DISCUSSION
Some natural and artificial particles and compounds (zymozan, rabbit erythrocytes, bacteria and bacterial wall components, etc) can activate the APC providing the formation of active C3 convertase (C3b/Bb). The action of activator is determined by interactions between the surface and C3 that can be spontaneously activated due to hydrolysis of the inner thioester bond. These interactions are greatly influenced by the C3b membrane microenvironment. There are at least three mechanisms for APC activation combining with each other. The activator can (1) provide more binding sites for C3b14,33; (2) protect bound APC convertase against I and H inhibitory serum pr~teins-'~; and (3) increase the C3b affinity for B and D factor^.'^^'' It has been reported that a cell nonactivator of APC can be converted to an activator by certain modifications. For example, human or sheep erythrocytes are converted to APC activators by de~ialization."-'~ Influenza or EBV infection also results in APC activation by blood cells.zo~21 Deficiency, dysfunction, or artificial inactivation of specific APC restrictors (DAF, C3b receptors, MIRL, and other^)^ may be the reason for APC activation by human erythrocytes and may play an important role in paroxysmal nocturnal hemoglobinuria and other Experiments on cells and liposomes have shown that APC activation can also be caused by the changes in the composition and physicochemical parameters of the lipid domains in plasma membrane.", 36 We have found that avidin attachment to human erythrocytes pretreated with BoSu converts them to APC activators. Biotin ester modifies amino groups of the erythrocyte membrane, which provides a covalent binding of biotin to the erythrocyte surface, and further noncovalent attachment of avidin." It can be suggested that noncovalently bound avidin induces transformations of the erythrocyte membrane that result in conversion to an APC activator;
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. Immobilization of Avidin on the Erythrocyte Membrane via the Biotin N-Hydroxysuccinimide Ester (Bl) and 6-Biotinylamidocaproic
Acid N-Hydroxysuccinimide Ester (82) however, it can not be excluded that decreased restriction of the membrane attack complex C6-9 is involved in avidin-induced lysis (eg, inactivation of HRF or MIRL). From the results of presented study we can note certain features characteristic of the avidin-induced activation of complement.
First, a high efficiency that manifests itself in complete lysis of avidin-carrying cells. As known, APC activation has been often detected only by binding or depletion of the APC components, but not by efficient lysis." Second, the activation was not limited by interspecies differences; avidincarrying biotinylated erythrocytes of all species tested were lysed by all heterologous sera. Third, avidin attachment eliminates homologous (autologous) APC restriction in all studied species. Fourth, acylation of avidin accompanied by the decrease of its positive charge prevents lysis. Finally, the lysis depends on the length of the cross-linking agent used for biotin attachment to the membrane.
The mechanism responsible for avidin-induced cell conversion to APC activator remains obscure. One can suggest several possibilities. Membrane-bound avidin may mask or change the activity of endogenous APC inhibitors (DAF, CP1, HRF, MIRL, sialic acids). However, it has been reported that APC restriction by these components is ~pecies-dependent.~.'~.~~ There is no evidence for the suggestion that different mechanisms of avidin-induced APC activation in homologous and heterologous sera operate in different species. Hence, the effect of avidin cannot be completely explained by species-dependent mechanisms.
At the same time, it is unclear how the introduction of a 7 A spacer between the membrane and avidin molecule increases the efficiency of masking. However, the possibility that steric masking is involved in avidin-induced hemolysis cannot be excluded.
On the other hand, membrane-bound avidin may provoke considerable alterations in the erythrocyte membrane resulting in APC activation. What are these alterations? Avidin is a glycoprotein (Mr, 66 Kd) composed of four subunits, each containing a binding site for biotin (kd, lo-'' m~l / L ) .~' The avidin molecule has a high positive charge (PI, -11). It can be suggested that interactions between avidin and charged membrane components (including sialoglycoproteins and other charged membrane components) produce significant changes in physicochemical properties of both protein and lipid domains in the cell membrane. spatial freedom of membrane-bound avidin, thus potentially increasing the number of its interactions with charged membrane components.
In a separate set of experiments we have examined the properties of acylated a~idin.'~ In this report, we have shown that acylated avidin has not only a lowered charge but also a reduced ability to cross-link biotin-containing components. These data suggest that membrane alterations may be caused not only by charge but also by capability for cooperative binding to biotin groups on the erythrocyte surface. Because the avidin molecule has four binding sites for biotin, avidin may "cross-link" biotin-carrying membrane components and thus change their arrangement and degree of freedom. The caproyl spacer increases the probability of the interaction between biotin-bound avidin and the next membrane-bound biotin molecules, which potentiates membrane alterations. Augmented agglutination activity of biotinylamidocaproylated erythrocytes supports this suggestion. Avidin-induced clustering may change the microenvironment of C3b and eliminate the APC restriction. It has been reported by several groups that under the conditions excluding activation of classical pathway a cell may be converted to an APC activator by polyclonal and monoclonal antibody binding." '' 7839 Maybe antibody binding in some of these works also induces unknown membrane alterations that eliminate restriction of complement. On the other hand, it was proposed that cross-linking, rearrangements, and clusterization of the membrane components controlling the binding and regulation of APC convertase might also be involved in APC activation, although it is not shown dire~tly.'"~ All these data lead to a consideration of the new type of "APC nonactivators" conversion to "APC activators," a conversion induced by steric rearrangement of membrane components. It is possible that avidin-induced conversion is the first direct example of this type of conversion.
At the present time we cannot provide unequivocal data on the mechanism underlying cell conversion to an APC activator by avidin. This issue may be clarified after the effects of membrane and avidin molecule modifications and immobilization procedure on avidin-induced APC activation are examined. We have recently shown that the avidin ability to induce APC activation strongly depends on the possibility to react with several biotin groups on the erythrocyte surface. At an equal number of avidin molecules on erythrocyte, hemolysis is dramatically decreased when part of the biotin binding sites of avidin is preoccupied by biotin or the number of membrane-bound biotin groups is insufficient for multipoint interaction with avidin.40 This finding corroborates the hypothesis that avidininduced clusterization of membrane components is involved in APC activation. At the same time, phenomena observed have not only pure scientific, but also great practical interest. It should be emphasized that special studies of the avidin effect on anticomplement resistance of cells are required before the avidin-biotin pair will be used in the clinic for gamma-scintigraphy,"' blood protein cleara n~e ,~' and drug targeting.43
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